Výsledky vyhledávání - "Cristel G de la O-Maldonado"

Factors associated with the desire to undergo post-mastectomy breast reconstruction in a Mexican breast cancer center

Autor: Paulina Bajonero-Canonico, Cynthia Villarreal-Garza, Melina Miaja-Avila, Ana S. Ferrigno, David Eugenio Hinojosa-Gonzalez, Brizio Moreno-Jaime, Carlos de la Cruz-de la Cruz, Cristel G de la O-Maldonado, Jorge Alberto Saldaña-Rodriguez, José Moral de la Rubia, Mariela Hernandez-Pavon

Publikováno v: Supportive Care in Cancer. 29:2679-2688

To assess the proportion of breast cancer patients treated with total mastectomy who are interested in undergoing breast reconstruction, the factors associated with their desire to undergo this procedure, and the motives stated for their decision. Wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccdbeb56b9f009c4712ac03098e1413c
https://doi.org/10.1007/s00520-020-05784-4

Zobrazit plný text záznamu

Abstract P6-11-15: Information gaps and perceived barriers to achieve breast reconstruction among patients with mastectomy in a public breast cancer center in Mexico

Autor: Jorge Alberto Saldaña-Rodriguez, José Moral de la Rubia, Cynthia Villarreal-Garza, Cristel G de la O-Maldonado, Melina Miaja-Avila, David Eugenio Hinojosa-Gonzalez, Paulina Bajonero-Canonico

Publikováno v: Cancer Research. 80:P6-11

Introduction: Multiple studies have reported that breast reconstruction (BR) after mastectomy is paramount in the global treatment of breast cancer (BC). Despite this, BR rates in Mexico are very low (7-16%), which may be explained by the fact that B

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ccf55745aeb32102bf85efd19be22230
https://doi.org/10.1158/1538-7445.sabcs19-p6-11-15

Zobrazit plný text záznamu

Cost and time savings of subcutaneous trastuzumab (SC-T) in a public health system in Mexico

Autor: Fernanda Mesa-Chavez, Omar Peña-Curiel, Héctor Díaz-Pérez, Marisol Garcia-Garcia, Servando Cardona-Huerta, Cynthia Villarreal-Garza, Cristel G de la O-Maldonado

Publikováno v: Journal of Clinical Oncology. 37:e18387-e18387

e18387 Background: The subcutaneous presentation of trastuzumab has been recently incorporated into the treatment regimen of HER2-positive breast cancer (BC). Its use has been associated with cost savings and reduced chair time, being especially suit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b01eac8487c611b63edc87e0306bc24b
https://doi.org/10.1200/jco.2019.37.15_suppl.e18387

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání